Cargando…

Genetic characterization of an aggressive optic nerve pilocytic glioma

Optic nerve glioma (ONG) is a rare, typically slow-growing WHO I grade tumor that affects the visual pathways. ONG is most commonly seen in the pediatric population, in association with neurofibromatosis type 1 syndrome. However, sporadic adult cases may also occur and may clinically behave more agg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Christopher S., Fliney, Greg, Fisayo, Adeniyi, An, Yi, Gopal, Pallavi P., Omuro, Antonio, Pointdujour-Lim, Renelle, Erson-Omay, E. Zeynep, Omay, S. Bulent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585354/
https://www.ncbi.nlm.nih.gov/pubmed/33098465
http://dx.doi.org/10.1007/s10014-020-00383-x
_version_ 1783599771715371008
author Hong, Christopher S.
Fliney, Greg
Fisayo, Adeniyi
An, Yi
Gopal, Pallavi P.
Omuro, Antonio
Pointdujour-Lim, Renelle
Erson-Omay, E. Zeynep
Omay, S. Bulent
author_facet Hong, Christopher S.
Fliney, Greg
Fisayo, Adeniyi
An, Yi
Gopal, Pallavi P.
Omuro, Antonio
Pointdujour-Lim, Renelle
Erson-Omay, E. Zeynep
Omay, S. Bulent
author_sort Hong, Christopher S.
collection PubMed
description Optic nerve glioma (ONG) is a rare, typically slow-growing WHO I grade tumor that affects the visual pathways. ONG is most commonly seen in the pediatric population, in association with neurofibromatosis type 1 syndrome. However, sporadic adult cases may also occur and may clinically behave more aggressively, despite benign histopathology. Genetic characterization of these tumors, particularly in the adult population, is lacking. A 39-year-old female presented with 1 month of progressive left-sided visual loss secondary to a enhancing mass along the left optic nerve sheath. Initial empiric management with focal radiotherapy failed to prevent tumor progression, prompting open biopsy which revealed a WHO I pilocytic astrocytoma of the optic nerve. Whole-exome sequencing of the biopsy specimen revealed somatic mutations in NF1,FGFR1 and PTPN11 that may provide actionable targets for molecularly guided therapies. Genetic characterization of ONG is lacking but is needed to guide the management of these rare but complex tumors. The genomic alterations reported in this case contributes to understanding the pathophysiology of adult sporadic ONG and may help guide future clinical prognostication and development of targeted therapies.
format Online
Article
Text
id pubmed-7585354
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-75853542020-10-26 Genetic characterization of an aggressive optic nerve pilocytic glioma Hong, Christopher S. Fliney, Greg Fisayo, Adeniyi An, Yi Gopal, Pallavi P. Omuro, Antonio Pointdujour-Lim, Renelle Erson-Omay, E. Zeynep Omay, S. Bulent Brain Tumor Pathol Case Report Optic nerve glioma (ONG) is a rare, typically slow-growing WHO I grade tumor that affects the visual pathways. ONG is most commonly seen in the pediatric population, in association with neurofibromatosis type 1 syndrome. However, sporadic adult cases may also occur and may clinically behave more aggressively, despite benign histopathology. Genetic characterization of these tumors, particularly in the adult population, is lacking. A 39-year-old female presented with 1 month of progressive left-sided visual loss secondary to a enhancing mass along the left optic nerve sheath. Initial empiric management with focal radiotherapy failed to prevent tumor progression, prompting open biopsy which revealed a WHO I pilocytic astrocytoma of the optic nerve. Whole-exome sequencing of the biopsy specimen revealed somatic mutations in NF1,FGFR1 and PTPN11 that may provide actionable targets for molecularly guided therapies. Genetic characterization of ONG is lacking but is needed to guide the management of these rare but complex tumors. The genomic alterations reported in this case contributes to understanding the pathophysiology of adult sporadic ONG and may help guide future clinical prognostication and development of targeted therapies. Springer Singapore 2020-10-24 2021 /pmc/articles/PMC7585354/ /pubmed/33098465 http://dx.doi.org/10.1007/s10014-020-00383-x Text en © The Japan Society of Brain Tumor Pathology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Hong, Christopher S.
Fliney, Greg
Fisayo, Adeniyi
An, Yi
Gopal, Pallavi P.
Omuro, Antonio
Pointdujour-Lim, Renelle
Erson-Omay, E. Zeynep
Omay, S. Bulent
Genetic characterization of an aggressive optic nerve pilocytic glioma
title Genetic characterization of an aggressive optic nerve pilocytic glioma
title_full Genetic characterization of an aggressive optic nerve pilocytic glioma
title_fullStr Genetic characterization of an aggressive optic nerve pilocytic glioma
title_full_unstemmed Genetic characterization of an aggressive optic nerve pilocytic glioma
title_short Genetic characterization of an aggressive optic nerve pilocytic glioma
title_sort genetic characterization of an aggressive optic nerve pilocytic glioma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585354/
https://www.ncbi.nlm.nih.gov/pubmed/33098465
http://dx.doi.org/10.1007/s10014-020-00383-x
work_keys_str_mv AT hongchristophers geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT flineygreg geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT fisayoadeniyi geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT anyi geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT gopalpallavip geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT omuroantonio geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT pointdujourlimrenelle geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT ersonomayezeynep geneticcharacterizationofanaggressiveopticnervepilocyticglioma
AT omaysbulent geneticcharacterizationofanaggressiveopticnervepilocyticglioma